Search Results

search

Search Filters

Organization
Enovis Corporation
Press Release 2025
Enovis™ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025
March 25, 2025 08:00 ET | Enovis Corporation
WILMINGTON, DE, March 25, 2025 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), a global medical technology innovator, will feature its expanding portfolio of foot and ankle solutions at this year’s...
logo Enovis.jpg
Enovis to Participate in Upcoming Investor Conferences
March 05, 2025 16:05 ET | Enovis Corporation
Wilmington, DE, March 05, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will...
logo Enovis.jpg
Enovis Announces Fourth Quarter and Full Year 2024 Results
February 26, 2025 06:01 ET | Enovis Corporation
Continued commercial momentum with fourth-quarter sales growth of 23% on a reported basis and strong adjusted EBITDA margin expansion Fourth-quarter Reconstructive sales grew 59% year-over-year on a...
logo Enovis.jpg
Enovis Announces Planned CEO Succession Process
February 26, 2025 06:00 ET | Enovis Corporation
Wilmington, DE, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), a leader in medical technology innovation, announced today that Matt Trerotola has...
logo Enovis.jpg
Enovis to Host Fourth Quarter and Full Year 2024 Results Conference Call on February 26th
January 29, 2025 07:00 ET | Enovis Corporation
Wilmington, DE, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call...
logo Enovis.jpg
Enovis™ Announces Leadership Change to International Surgical Business
January 17, 2025 06:00 ET | Enovis Corporation
Wilmington, DE, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Enovis™, a global medical technology innovator headquartered in the United States, announced recently that Davide Visentin will succeed Dr....
logo Enovis.jpg
Enovis to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
January 06, 2025 16:15 ET | Enovis Corporation
Wilmington, DE, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will meet with...
logo Enovis.jpg
Enovis to Participate in Upcoming Investor Conferences
November 18, 2024 16:10 ET | Enovis Corporation
Wilmington, DE, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will...
logo Enovis.jpg
Enovis Announces Third Quarter 2024 Results
November 06, 2024 06:00 ET | Enovis Corporation
Continued commercial momentum with third-quarter sales growth of 21% on a reported basis and strong adjusted EBITDA margin expansionReconstructive sales grew 57% Y/Y on a reported basis and 9%...
logo Enovis.jpg
Enovis to Host Third Quarter 2024 Results Conference Call on November 6th
October 10, 2024 07:00 ET | Enovis Corporation
Wilmington, DE, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call...